ADC Weekly Digest - 21 to 26 April 2024

ADC Weekly Digest - 21 to 26 April 2024

Regulatory
Breast cancer drug Enhertu’s breakthrough results unveiled at GBCC 2024
Commercial
Bristol Myers Squibb finalizes a Global Strategic License and Collaboration Agreement with SystImmune for BL-B01D1,...
Commercial
Tharimmune Enters Option Agreement for Crucial Technologies in HER2/HER3 Antibody Drug Conjugates
Commercial
Salubris Biotherapeutics Secures $35 Million Investment and Unveils Pipeline Advancements